Use of mometasone furoate for treating lower airway passage and

Details Use of mometasone furoate for treating lower airway passage and Use of mometasone furoate for treating lower airway passage and

1997-08-14

1999-03-30

Clardy, S. Mark

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514826, 514958, A61K 3158

Patent

active

058890157

ABSTRACT:
The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.

REFERENCES:
patent: 4472393 (1984-09-01), Shaprio
Lee, Henry J. et al. "Anti-inflammatory steroids: research trends and new compounds", Drugs of Today, 25(9):577-588, 1989.
PR Newswire, Nov. 30, 1988, 4 pages.
Business Wire, Nov. 14, 1990, 5 pages.
Predicasts Marketletter, Mar. 30, 1992, 3 pages.
I. M. Richards et al., "Novel Steroid-Based Inhibitors of Lung Inflammation," Clinical and Experimental Allergy, vol. 22, pp. 432-439, 1992.
C. J. Wang et al., "A Sensitive Enzyme Immunoassay (EIA) for Quantitation of Mometasone Fuorate (SCH 32088) Directly in Biological Fluids," Abstract 2119, FASEB J., vol. 6, No. 4, p. A1302, 1992.
C-J. Wang et al., "A Competitive Enzyme Immunoassay for the Direct Determination of Mometasone Furoate (SCH 32088) in Human Plasma," Journal of Pharmaceutical and Biomedical Analysis, vol. 10, pp. 473-479, 1992.
D. Debrovner, "Why Asthamatics Need You," American Druggist, pp. 24-27, Aug. 1994.
M. Drouin et al., "Once Daily Mometasone Furoate Aqueous Nasal Spray is as Effective as Twice Daily Beclomethasone Dipropionate for Treating Perennial Allergic Rhinitis Patients," Annals of Allergy, Asthma & Immunology, vol. 77, pp. 153-160, 1996.
L. Kanter, "Inhaled Fluticasone Propionate in the Treatment of Asthma," Advances in Therapy, vol. 14, pp. 1-7, 1997.
Monograph for FLOVENT.RTM. Inhalation Aerosol, Physicians' Desk Reference, 52nd Ed., Medical Economics Co., Montvale, New Jersey U.S.A., pp. 1027-1030, 1998.

Affiliated with

Also associated with

Rating

Use of mometasone furoate for treating lower airway passage and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of mometasone furoate for treating lower airway passage and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of mometasone furoate for treating lower airway passage and will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1215406